Detalles de la búsqueda
1.
Novel antibody-antibiotic conjugate eliminates intracellular S. aureus.
Nature;
527(7578): 323-8, 2015 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-26536114
2.
Novel staphylococcal glycosyltransferases SdgA and SdgB mediate immunogenicity and protection of virulence-associated cell wall proteins.
PLoS Pathog;
9(10): e1003653, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24130480
3.
Combination of two anti-CD5 monoclonal antibodies synergistically induces complement-dependent cytotoxicity of chronic lymphocytic leukaemia cells.
Br J Haematol;
163(2): 182-93, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23927424
4.
Affinity capture of biotinylated proteins at acidic conditions to facilitate hydrogen/deuterium exchange mass spectrometry analysis of multimeric protein complexes.
Anal Chem;
85(15): 7052-9, 2013 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-23534402
5.
Discovery of neutralizing SARS-CoV-2 antibodies enriched in a unique antigen specific B cell cluster.
PLoS One;
18(9): e0291131, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37729215
6.
Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform.
MAbs;
11(4): 666-680, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31046547
7.
Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses: A Phase 2 Randomized Clinical Trial.
JAMA Oncol;
4(4): e175245, 2018 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29423521
8.
Simultaneous Targeting of Two Distinct Epitopes on MET Effectively Inhibits MET- and HGF-Driven Tumor Growth by Multiple Mechanisms.
Mol Cancer Ther;
16(12): 2780-2791, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28802255
9.
Sym015: A Highly Efficacious Antibody Mixture against MET-Amplified Tumors.
Clin Cancer Res;
23(19): 5923-5935, 2017 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28679766
10.
The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal Cancer.
Clin Cancer Res;
22(13): 3260-7, 2016 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26888827
11.
Molecular characterization of the circulating anti-HIV-1 gp120-specific B cell repertoire using antibody phage display libraries generated from pre-selected HIV-1 gp120 binding PBLs.
J Immunol Methods;
297(1-2): 187-201, 2005 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15777942
12.
Targeting Three Distinct HER2 Domains with a Recombinant Antibody Mixture Overcomes Trastuzumab Resistance.
Mol Cancer Ther;
14(3): 669-80, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25612619
13.
Pan-HER, an Antibody Mixture Simultaneously Targeting EGFR, HER2, and HER3, Effectively Overcomes Tumor Heterogeneity and Plasticity.
Clin Cancer Res;
21(18): 4110-22, 2015 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25908781
14.
Rational identification of an optimal antibody mixture for targeting the epidermal growth factor receptor.
MAbs;
3(6): 584-95, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22123060
15.
Sym004: a novel synergistic anti-epidermal growth factor receptor antibody mixture with superior anticancer efficacy.
Cancer Res;
70(2): 588-97, 2010 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20068188
16.
Identification of talin head domain as an immunodominant epitope of the antiplatelet antibody response in patients with HIV-1-associated thrombocytopenia.
Blood;
104(13): 4054-62, 2004 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15315970
Resultados
1 -
16
de 16
1
Próxima >
>>